Abiraterone Acetate: A Guide to Its Use in Metastatic Castration-Resistant Prostate Cancer

Author： Scott Lesley J. Yang Lily P.H. Lyseng-Williamson Katherine A.

ISSN： 1170-229X

Source： Drugs & Aging, Vol.29, Iss.3, 2012-03, pp. : 243-248

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Abiraterone Acetate: In Metastatic Castration-Resistant Prostate Cancer

By Yang Lily P.H.

Drugs, Vol. 71, Iss. 15, 2011-10 ,pp. : 2067-2077

Adis International

Access to resources Recommend Favorite

Abiraterone acetate for castration resistant prostate cancer

By Shah Shreya Ryan Charles

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 4, 2010-04 ,pp. : 563-570

Informa Healthcare

Access to resources Recommend Favorite

Sipuleucel-T: In Metastatic Castration-Resistant Prostate Cancer

By Plosker Greg L.

Drugs, Vol. 71, Iss. 1, 2011-01 ,pp. : 101-108

Adis International

Access to resources Recommend Favorite

Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment

By Badrising Sushil van der Noort Vincent van Oort Inge M. van den Berg H. Pieter Los Maartje Hamberg Paul Coenen Jules L. van den Eertwegh Alfons J. M. de Jong Igle J. Kerver Emile D. van Tinteren Harm Bergman Andries M.

Cancer, Vol. 120, Iss. 7, 2014-04 ,pp. : 968-975

Blackwell Publishing

Access to resources Recommend Favorite

A Rapid, Direct and Validated HPLC- Fluorescence Method for the Quantification of Abiraterone and Abiraterone Acetate in Urine and Serum Samples from Patients with Castration- Resistant Prostate Cancer

Current Pharmaceutical Analysis, Vol. 14, Iss. 3, 2018-04 ,pp. : 233-238

Bentham Science Publishers

Access to resources Recommend Favorite